Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Transthyretin is a transport protein that transports thyroid hormones and retinol (vitamin A). The Transthyretin pipeline drugs market research report outlays comprehensive information on the Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics development with respective active and dormant or discontinued projects.
Transthyretin Pipeline Drugs Market Segmentation by Therapy Areas
The key therapy areas in the Transthyretin pipeline drugs market are metabolic disorders, ophthalmology, central nervous system, gastrointestinal, immunology, and infectious disease.
Transthyretin Pipeline Drugs Market Analysis, by Therapy Areas, 2022 (%)
For more Transthyretin pipeline drugs therapy area insights, download a free report sample
Transthyretin Pipeline Drugs Market Segmentation by Mechanism of Actions
The key mechanism of actions in the Transthyretin pipeline drugs market are Transthyretin Inhibitor and Transthyretin Activator.
Transthyretin Pipeline Drugs Market Analysis, by Mechanism of Actions, 2022 (%)
For more Transthyretin pipeline drugs mechanism of actions insights, download a free report sample
Transthyretin Pipeline Drugs Market Segmentation by Routes of Administration
The key routes of administration in the Transthyretin pipeline drugs market are intravenous, subcutaneous, oral, and parenteral.
Transthyretin Pipeline Drugs Market Analysis, by Routes of Administration, 2022 (%)
For more Transthyretin pipeline drugs routes of administration insights, download a free report sample
Transthyretin Pipeline Drugs Market Segmentation by Molecule Types
The key molecule types in the Transthyretin pipeline drugs market are small molecule, antisense RNAi oligonucleotide, monoclonal antibody, antisense oligonucleotide, gene therapy, synthetic peptide, antibody, and fusion protein.
Transthyretin Pipeline Drugs Market Analysis, by Molecule Types, 2022 (%)
For more Transthyretin pipeline drugs molecule type insights, download a free report sample
Competitive Landscape
Some of the leading companies in the Transthyretin pipeline drugs market are ADRx Inc, Akcea Therapeutics Inc, Alexion Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Autotac Bio Inc, BridgeBio Pharma Inc, BSIM Therapeutics SA, Corino Therapeutics Inc, Covalent Bioscience Inc, and Galmed Pharmaceuticals Ltd.
Transthyretin Pipeline Drugs Market Analysis, by Companies, 2022 (%)
To know more about the Transthyretin pipeline drugs companies, download a free report sample
Transthyretin Pipeline Drugs Market Report Overview
| Key Therapy Areas | Metabolic Disorders, Ophthalmology, Central Nervous System, Gastrointestinal, Immunology, and Infectious Disease |
| Key Mechanism of Actions | Transthyretin Inhibitor and Transthyretin Activator |
| Key Routes of Administration | Intravenous, Subcutaneous, Oral, and Parenteral |
| Key Molecule Types | Small Molecule, Antisense RNAi Oligonucleotide, Monoclonal Antibody, Antisense Oligonucleotide, Gene Therapy, Synthetic Peptide, Antibody, and Fusion Protein |
| Leading Companies | ADRx Inc, Akcea Therapeutics Inc, Alexion Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Autotac Bio Inc, BridgeBio Pharma Inc, BSIM Therapeutics SA, Corino Therapeutics Inc, Covalent Bioscience Inc, and Galmed Pharmaceuticals Ltd |
Segments Covered in the Report
Transthyretin Pipeline Drugs Market Therapy Areas Outlook
- Metabolic Disorders
- Ophthalmology
- Central Nervous System
- Gastrointestinal
- Immunology
- Infectious Disease
Transthyretin Pipeline Drugs Market Mechanism of Actions Outlook
- Transthyretin Inhibitor
- Transthyretin Activator
Transthyretin Pipeline Drugs Market Routes of Administration Outlook
- Intravenous
- Subcutaneous
- Oral
- Parenteral
Transthyretin Pipeline Drugs Market Molecule Types Outlook
- Small Molecule
- Antisense RNAi Oligonucleotide
- Monoclonal Antibody
- Antisense Oligonucleotide
- Gene Therapy
- Synthetic Peptide
- Antibody
- Fusion Protein
Scope
This report provides:
- A snapshot of the global therapeutic landscape for Transthyretin (ATTR or Prealbumin or TBPA or TTR).
- Reviews of Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Pipeline products based on various stages of development ranging from pre-registration to discovery and undisclosed stages.
- Descriptive drug profiles for the pipeline products which includes product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.
- Reviews of key players involved in Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics and enlists all their major and minor projects.
- Assessment of Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type.
- Summaries of all the dormant and discontinued pipeline projects.
- Reviews of the latest news and deals related to Transthyretin (ATTR or Prealbumin or TBPA or TTR) targeted therapeutics.
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage.
- Identify and understand the targeted therapy areas and indications for Transthyretin (ATTR or Prealbumin or TBPA or TTR). Identify the use of drugs for target identification and drug repurposing.
- Identify potential new clients or partners in the target demographic.
- Develop strategic initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics.
- Devise corrective measures for pipeline projects by understanding Transthyretin (ATTR or Prealbumin or TBPA or TTR) development landscape.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
Akcea Therapeutics Inc
Alexion Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Autotac Bio Inc
BridgeBio Pharma Inc
BSIM Therapeutics SA
Corino Therapeutics Inc
Covalent Bioscience Inc
Galmed Pharmaceuticals Ltd
Novo Nordisk AS
Proclara Biosciences Inc
Regeneron Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas of the Transthyretin pipeline drugs market?
The key therapy areas in the Transthyretin pipeline drugs market are metabolic disorders, ophthalmology, central nervous system, gastrointestinal, immunology, and infectious disease.
-
What are the key mechanism of actions in the Transthyretin pipeline drugs market?
The key mechanism of actions in the Transthyretin pipeline drugs market are Transthyretin Inhibitor and Transthyretin Activator.
-
What are the key routes of administration in the Transthyretin pipeline drugs market?
The key routes of administration in the Transthyretin pipeline drugs market are intravenous, subcutaneous, oral, and parenteral.
-
What are the key molecule types in the Transthyretin pipeline drugs market?
The key molecule types in the Transthyretin pipeline drugs market are small molecule, antisense RNAi oligonucleotide, monoclonal antibody, antisense oligonucleotide, gene therapy, synthetic peptide, antibody, and fusion protein.
-
Which are the key companies in the Transthyretin pipeline drugs market?
The key companies in the Transthyretin pipeline drugs market are ADRx Inc, Akcea Therapeutics Inc, Alexion Pharmaceuticals Inc, Alnylam Pharmaceuticals Inc, Autotac Bio Inc, BridgeBio Pharma Inc, BSIM Therapeutics SA, Corino Therapeutics Inc, Covalent Bioscience Inc, and Galmed Pharmaceuticals Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Other Diseases reports